{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:03:42Z","timestamp":1784649822916,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.radonc.2016.06.020","type":"journal-article","created":{"date-parts":[[2016,7,9]],"date-time":"2016-07-09T17:34:59Z","timestamp":1468085699000},"page":"228-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Patient reported quality of life after helical IMRT based concurrent chemoradiation of locally advanced anal cancer"],"prefix":"10.1016","volume":"120","clinical-trial-number":[{"clinical-trial-number":"nct00754078","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Kurian","family":"Joseph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa J.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Warkentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee-anne","family":"Polkosnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawaid","family":"Usmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Tankel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Severin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tirath","family":"Nijjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Schiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarence","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Field","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2016.06.020_b0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cncr.20364","article-title":"Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973\u20132000","volume":"101","author":"Johnson","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2016.06.020_b0010","first-page":"1049","article-title":"Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research","volume":"348","year":"1996"},{"key":"10.1016\/j.radonc.2016.06.020_b0015","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.06.020_b0020","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.06.020_b0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02604287","article-title":"Combined therapy for cancer of the anal canal","volume":"24","author":"Nigro","year":"1981","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.radonc.2016.06.020_b0030","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.radonc.2016.06.020_b0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00066-010-2175-5","article-title":"Quality of life outcomes in patients with anal cancer after combined radiochemotherapy","volume":"187","author":"Welzel","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.06.020_b0040","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ijrobp.2014.06.061","article-title":"Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer","volume":"90","author":"Han","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.06.020_b0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.06.020_b0050","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.radonc.2015.08.008","article-title":"Prospective phase II study of tomotherapy based chemoradiation treatment for locally advanced anal cancer","volume":"117","author":"Joseph","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.06.020_b0055","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1200\/JCO.2007.12.0170","article-title":"Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience","volume":"25","author":"Salama","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.06.020_b0060","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2016.06.020_b0065","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/j.ejca.2009.08.014","article-title":"Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer","volume":"45","author":"Whistance","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2016.06.020_b0070","unstructured":"Fayers PM, Aaronson NK, Bjordal K, et al. The EORTC QLQ-C30 scoring manual. 3rd ed. European Organisation for Research and Treatment of Cancer; 2001. <http:\/\/www.eortc.be\/qol\/files\/SCManualQLQ-C30.pdf>."},{"key":"10.1016\/j.radonc.2016.06.020_b0075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","article-title":"Interpreting the significance of changes in health-related quality-of-life scores","volume":"16","author":"Osoba","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.06.020_b0080","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.ejca.2012.02.059","article-title":"Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30","volume":"48","author":"Cocks","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2016.06.020_b0085","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.radonc.2007.12.004","article-title":"Radiochemotherapy of locally advanced anal canal carcinoma: prospective assessment of early impact on the quality of life (randomized trial ACCORD 03)","volume":"87","author":"Tournier-Rangeard","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.06.020_b0090","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/sj.bjc.6690567","article-title":"Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy","volume":"80","author":"Allal","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2016.06.020_b0095","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3109\/0284186X.2013.770599","article-title":"Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors","volume":"52","author":"Bentzen","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2016.06.020_b0100","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/cncr.24906","article-title":"Long-term quality of life after radiotherapy for the treatment of anal cancer","volume":"116","author":"Das","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2016.06.020_b0105","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.clon.2004.05.007","article-title":"Quality of life after non-surgical treatment of anal carcinoma: a case control study of long-term survivors","volume":"16","author":"Jephcott","year":"2004","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2016.06.020_b0110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1748-717X-5-41","article-title":"Quality of life and tumor control after short split-course chemoradiation for anal canal carcinoma","volume":"5","author":"Provencher","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2016.06.020_b0115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0167-8140(99)00096-1","article-title":"Curative-intent radiation therapy in anal carcinoma: quality of life and sphincter function","volume":"52","author":"Vordermark","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.06.020_b0120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/00365521.2010.545832","article-title":"\u201cPelvic radiation disease\u201d: new understanding and new solutions for a new disease in the era of cancer survivorship","volume":"46","author":"Andreyev","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.radonc.2016.06.020_b0125","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3109\/0284186X.2012.734924","article-title":"Dose-response relationships for an atomized symptom of fecal incontinence after gynecological radiotherapy","volume":"52","author":"Alevronta","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2016.06.020_b0130","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1016\/j.ijrobp.2012.03.065","article-title":"Mean absorbed dose to the anal-sphincter region and fecal leakage among irradiated prostate cancer survivors","volume":"84","author":"Alsadius","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.06.020_b0135","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00066-005-1313-y","article-title":"Dose-response relations for anal sphincter regarding fecal leakage and blood or phlegm in stools after radiotherapy for prostate cancer. Radiobiological study of 65 consecutive patients","volume":"181","author":"Mavroidis","year":"2005","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.06.020_b0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.radonc.2013.05.037","article-title":"Faecal incontinence after chemoradiotherapy in anal cancer survivors: long-term results of a national cohort","volume":"108","author":"Bentzen","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.06.020_b0145","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.radonc.2010.04.023","article-title":"Temporary sacral nerve stimulation for faecal incontinence following pelvic radiotherapy","volume":"97","author":"Maeda","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.06.020_b0150","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s10350-007-0296-4","article-title":"Radiation-induced sequelae affecting the continence organ: incidence, pathogenesis, and treatment","volume":"50","author":"Petersen","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.radonc.2016.06.020_b0155","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/jsm.12751","article-title":"Testosterone and body composition in men after treatment for rectal cancer","volume":"12","author":"Buchli","year":"2015","journal-title":"J Sex Med"},{"key":"10.1016\/j.radonc.2016.06.020_b0160","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2004.12.017","article-title":"Testicular dose and hormonal changes after radiotherapy of rectal cancer","volume":"75","author":"Hermann","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.06.020_b0165","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.ijrobp.2008.10.011","article-title":"Risk of hypogonadism from scatter radiation during pelvic radiation in male patients with rectal cancer","volume":"74","author":"Yau","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.06.020_b0170","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1371\/journal.pmed.0050202","article-title":"Faecal and urinary incontinence after multimodality treatment of rectal cancer","volume":"5","author":"Lange","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.radonc.2016.06.020_b0175","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1007\/s00520-015-2879-2","article-title":"Systematic review of the quality of life issues associated with anal cancer and its treatment with radiochemotherapy","volume":"23","author":"Sodergren","year":"2015","journal-title":"Support Care Cancer"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781401631180X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781401631180X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T16:52:11Z","timestamp":1536598331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781401631180X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S016781401631180X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2016.06.020","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient reported quality of life after helical IMRT based concurrent chemoradiation of locally advanced anal cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2016.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}